In vivo flow cytometry reveals an anti-metastatic effect of Rujifang in triple-negative breast cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Fuli,Zhang

第一单位： Med-X Research Institute and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.

作者： Fuli,Zhang ^[1] ; Hongliang,Li ^[2] ; Xuan,Lin ^[3] ; Xi,Zhu ^[4] ; Xuezhang,Chen ^[2] ; Bin,Wang ^[2] ; Zhixia,Zhu ^[2] ; Xikang,Chen ^[2] ; Guiwen,Liang ^[2] ; Jingtao,Zhang ^[2] ; Xunbin,Wei ^[1] ; Huaqin,Tian ^[5]

作者单位： Med-X Research Institute and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China. ^[1] Cancer Center, Foshan Hospital of Traditional Chinese Medicine, Foshan, China. ^[2] Cancer Center, The 8th Clinical Medical College of Guangzhou University of Chinese Medicine, Foshan, China. ^[3] School of Rehabilitation, Kunming Medical University, Kunming, China. ^[4] Institute of Medical Technology, Peking University Health Science Center, Beijing, China. ^[5] Biomedical Engineering Department, Peking University, Beijing, China. ^[6] Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China. ^[7]

关键词 Rujifang breast cancer circulating tumor cells in vivo flow cytometry metastasis

主题词动物(Animals);人类(Humans);流式细胞术(Flow Cytometry);肿瘤细胞, 循环(Neoplastic Cells, Circulating);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);肿瘤微环境(Tumor Microenvironment)

DOI 10.1002/cyto.a.24768

PMID 37276218

发布时间 2023-09-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交